James is a pulmonary and critical care physician specializing in sarcoidosis. When one of my patients was first diagnosed with sarcoidosis, her specialist gave her two options: take steroids or join a ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...

Tamika Jackson has a vision for the open clinic she’s been planning. Attendees will be able to get their teeth checked, stock up on groceries from a food pantry, and pick up coats at a clothing drive.

Treatment with intranasal carbetocin was not associated with a statistically significant improvement in hyperphagia compared with placebo. Topline results were announced from a phase 3 trial ...

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients ...

This study reviewed all industry-sponsored phase I clinical trial protocols activated at one of eight Sarah Cannon Research Institute drug development units between 2021 and 2024. The review focused ...

Two clinical trials of Merck’s pulmonary arterial hypertension (PAH) drug Winrevair were so conclusive that the studies were halted within the last year because the efficacy of the treatment was ...

Acadia Pharma (NASDAQ:ACAD) shares fell in the premarket on Wednesday after the biotech announced that its experimental therapy for a rare genetic condition known as Prader-Willi syndrome failed in a ...

A specially developed cannabis extract relieves chronic lower back pain, according to a clinical trial published Wednesday that experts are calling the first high-quality evidence that something in ...